Loading…
Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain
One characteristic feature of Alzheimer's disease is the deposition of amyloid β-peptide (Aβ) as amyloid plaques within specific regions of the human brain. Aβ is derived from the amyloid β-peptide precursor protein (β-APP) by the intramembranous cleavage activity of γ-secretase. Studies...
Saved in:
Published in: | The Journal of biological chemistry 2003-07, Vol.278 (27), p.24277 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | One characteristic feature of Alzheimer's disease is the deposition of amyloid β-peptide (Aβ) as amyloid plaques within specific
regions of the human brain. Aβ is derived from the amyloid β-peptide precursor protein (β-APP) by the intramembranous cleavage
activity of γ-secretase. Studies in cells have revealed that γ-secretase is a large multimeric membrane-bound protein complex
that is functionally dependent on several proteins, including presenilin, nicastrin, Aph-1, and Pen-2. However, the precise
biochemical and molecular nature of γ-secretase is as yet to be fully elucidated, and no investigations have analyzed γ-secretase
in human brain. To address this we have developed a novel in vitro γ-secretase activity assay using detergent-solubilized cell membranes and a β-APP-derived fluorescent probe. We report that
human brain-derived γ-secretase activity co-purifies with a high molecular weight protein complex comprising presenilin,
nicastrin, Aph-1, and Pen-2. The inhibitor profile and solubility characteristics of brain-derived γ-secretase are similar
to those described in cells, and proteolysis occurs at the Aβ 40 - and Aβ 42 -generating cleavage sites. The ability to isolate γ-secretase from post-mortem human brain may facilitate the identification
of brain-specific modulators of β-APP processing and provide new insights into the biology of this important factor in the
pathogenesis of Alzheimer's disease. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M211992200 |